Free Trial

Edgewise Therapeutics (EWTX) Earnings Date, Estimates & Call Transcripts

Edgewise Therapeutics logo
$12.33 +0.91 (+7.97%)
Closing price 04/14/2025 04:00 PM Eastern
Extended Trading
$12.35 +0.02 (+0.16%)
As of 08:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Edgewise Therapeutics Earnings Summary

Upcoming
Earnings Date
May. 8Before Market OpensEstimated
Consensus EPS
(Mar. 3)
-$0.39
Actual EPS
(Mar. 3)
-$0.42 Missed By -$0.03

Edgewise Therapeutics announced Q4 2024 earnings on March 3, 2025, reporting an EPS of -$0.42, which missed analysts' consensus estimates of -$0.39 by $0.03. With a trailing EPS of -$1.45, Edgewise Therapeutics' earnings are expected to decrease next year, from ($1.45) to ($1.86) per share.

Q4 2024 Earnings Resources

EWTX Upcoming Earnings

Edgewise Therapeutics' Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Edgewise Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Edgewise Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

EWTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Remove Ads

Edgewise Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.44-$0.40-$0.42
Q2 20251-$0.49-$0.49-$0.49
Q3 20251-$0.51-$0.51-$0.51
Q4 20251-$0.55-$0.55-$0.55
FY 20255-$1.99-$1.95-$1.97
Q1 20261-$0.52-$0.52-$0.52
Q2 20261-$0.55-$0.55-$0.55
Q3 20261-$0.58-$0.58-$0.58
Q4 20261-$0.60-$0.60-$0.60
FY 20264($2.25)($2.25)($2.25)
Remove Ads

Edgewise Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/8/2025
(Estimated)
-------
3/3/2025Q4 2024-$0.39-$0.42 -$0.03-$0.42--
11/7/2024Q3 2024-$0.37-$0.36+$0.01-$0.36--
8/8/2024--$0.36-$0.34+$0.02-$0.34--
5/9/2024Q1 2024-$0.39-$0.33+$0.06-$0.33--
2/22/2024Q4 2023-$0.44-$0.47 -$0.03-$0.47--
11/9/2023Q3 2023-$0.40-$0.41 -$0.01-$0.41--
8/10/2023Q2 2023-$0.41-$0.34+$0.07-$0.34--
5/11/2023Q1 2023-$0.37-$0.36+$0.01-$0.36--

Edgewise Therapeutics Earnings - Frequently Asked Questions

Edgewise Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on EWTX's earnings history.

In the previous quarter, Edgewise Therapeutics (NASDAQ:EWTX) missed the analysts' consensus estimate of ($0.39) by $0.03 with a reported earnings per share (EPS) of ($0.42). Learn more on analysts' earnings estimate vs. EWTX's actual earnings.

Edgewise Therapeutics (NASDAQ:EWTX) has a recorded net income of -$100.16 million. EWTX has generated -$1.45 earnings per share over the last four quarters.

Edgewise Therapeutics's earnings are expected to decrease from ($1.45) per share to ($1.86) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:EWTX) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners